12 Best Performing Stocks in the Last 6 Months

Page 11 of 11

1. Regencell Bioscience Holdings Limited (NASDAQ:RGC)

6-Month Performance: 13,790.00%

Number of Hedge Fund Holders: N/A

Regencell Bioscience Holdings Limited (NASDAQ:RGC) is one of the best-performing stocks in the last 6 months. On June 17, Regencell Bioscience Holdings Limited (NASDAQ:RGC) announced that it had carried out a 38-for-1 forward stock split.

For every share held on the record date, investors received 37 additional shares as a stock bonus. This stock split was announced on June 2.

Regencell Bioscience Holdings Limited (NASDAQ:RGC) pointed out that this stock split is aimed at improving liquidity in the market for the company’s ordinary shares and making the shares more accessible to investors.

In the past 6 months, Regencell Bioscience Holdings Limited (NASDAQ:RGC) has gone up dramatically, surging by more than 13,000% as of July 29.

The rally can be attributed in part to the completion of the stock split by Regencell Bioscience Holdings Limited (NASDAQ:RGC), which helped push the stock price higher.

Regencell Bioscience Holdings Limited (NASDAQ:RGC) is a Hong Kong-based bioscience company focused on researching, developing, and commercializing traditional Chinese medicine (TCM) for the treatment of attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).

While we acknowledge the potential of RGC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than RGC and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Tech Stocks Under $50 To Invest In and 13 Best Large Cap Stocks to Buy Right Now.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 11 of 11